Albipagrastim alf for febrile neutropenia

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trial registered. A trial in people is registered. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 24 Jul 2026: Trial registered, NCT07724756

The trials

NCT07724756: Phase II Study of QLC2519 in Pediatric Solid Tumor Participants

State
Under way
Phase
Phase 2
People
18 planned
Started
26 Jun 2026
Primary completion
26 Jun 2027
Arms
Treatment Group
Results
None posted
  1. 24 Jul 2026: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Trial registered

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.